Amnon Peled is a distinguished professional who serves as the Director at the Gene Therapy Institute of Hadassah University Hospital from 2021 to 2024. They have held the position of Chief Scientific Officer at Biokine Therapeutics Ltd., Alonbio, and Sakura Bio from 2000 to 2024. Amnon is also a Professor and Principal Investigator at Hadassah Medical Center during the same time period. Their academic background includes a Bachelor of Agriculture from The Hebrew University of Jerusalem, a Master's in Cell Biology and Histology from Tel Aviv University, and a PhD in Cellular and Molecular Biology from the Weizmann Institute of Science. Amnon further advanced their expertise with multiple postdoctoral studies, including fields such as Oncology, Chemokine biology, and Chemokine in stem cells.
This person is not in the org chart
This person is not in any teams
This person is not in any offices